$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
富马酸二甲酯在华获批,多发性硬化症临床治疗市场需求大增
2025-10-19 11:44:20
Check Details
源于冬虫夏草的药物芬戈莫德真的可以治疗多发性硬化症吗?
2025-10-19 11:44:20
Check Details
多发性硬化症新药-奥扎莫德
2025-10-19 11:44:20
Check Details
重磅多发性硬化症药物芬戈莫德在我国上市
2025-10-19 11:44:20
Check Details
芬戈莫德在中国上市了吗?厦门能买到吗?
2025-10-19 11:44:20
Check Details
奥扎莫德治疗成人复发型多发性硬化症临床数据
2025-10-19 11:44:20
Check Details
给大家讲讲奥扎莫德这个新药物
2025-10-19 11:44:20
Check Details
源于冬虫夏草的药物芬戈莫德如何有效治疗多发性硬化症?
2025-10-19 11:44:20
Check Details
全世界首款治疗多发性硬化症的口服药物—芬戈莫德
2025-10-19 11:44:20
Check Details
芬戈莫德的副作用多不多?使用时有哪些需要注意的
2025-10-19 11:44:20
Check Details
奥扎莫德成人复发型多发性硬化症临床数据
2025-10-19 11:44:20
Check Details
芬戈莫德治疗多发性硬化症的效果怎么样?有什么副作用?
2025-10-19 11:44:20
Check Details
1
2
...
3267
3268
3269
3270
3271
3272
3273
...
10230
10231
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Capmatinib (Tabrecta): Oral Targeted Therapy for MET Exon 14 Skipping-Mutated NSCLC
2
Amivantamab Plus Lazertinib: A Chemotherapy-Free First-Line Option in EGFR-Mutated NSCLC
3
Midostaurin (Rydapt): Dosing Essentials in FLT3-Mutated AML and Systemic Mastocytosis
4
Lapatinib: An Oral Dual EGFR/HER2 TKI in HER2-Positive Breast Cancer
5
Filgotinib (Jyseleca) Overseas Guide: JAK1 Inhibitor for Rheumatoid Arthritis and Ulcerative Colitis
6
FDA Approves LISRAYA (brepocitinib): First Oral Targeted Therapy for Adults with Dermatomyositis
7
Elagolix for Endometriosis Pain: Indications and Usage Guidelines
8
Bosentan vs. Antihypertensives: What PAH Patients Need to Know
9
Letermovir: Proper Usage and Important Precautions
10
FDA Approves Daraxonrasib, Marking Milestone in Metastatic Pancreatic Cancer Treatment
11
Brensocatib for Non-Cystic Fibrosis Bronchiectasis: Patient Selection, ASPEN Data, and Safety Profile
12
Mirdametinib Mechanism and Clinical Guide: MEK Inhibitor for NF1 Plexiform Neurofibromas